Patents by Inventor Satish Rajanikant Soudagar

Satish Rajanikant Soudagar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-thrombotic compounds
    Patent number: 10105353
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: October 23, 2018
    Assignee: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki Moje
  • Anti-Thrombotic Compounds
    Publication number: 20140038924
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: October 3, 2013
    Publication date: February 6, 2014
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Anti-Thrombotic Compounds
    Publication number: 20140031320
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 30, 2014
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Anti-Thrombotic Compounds
    Publication number: 20130316987
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 28, 2013
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Anti-Thrombotic Compounds
    Publication number: 20130316986
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 28, 2013
    Applicant: IPCA LABORATORIES LIMITED
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki MOJE
  • Solid forms of methyl (7aS,2?S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate
    Patent number: 8536337
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 17, 2013
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki Moje
  • ANTI-THROMBOTIC COMPOUNDS
    Publication number: 20120329762
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: January 6, 2012
    Publication date: December 27, 2012
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Nellithanath Thankachen Byju, Gaurav Sahal, Arpana Prashant Mathur, Sanjay Pandurang Gawade, Dinesh Kanji Bhadra, Devki Moje
  • ANTI-THROMBOTIC COMPOUNDS
    Publication number: 20120329763
    Abstract: New compounds, namely, (7aS,2?S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.
    Type: Application
    Filed: March 23, 2012
    Publication date: December 27, 2012
    Inventors: Ashok KUMAR, Satish Rajanikant SOUDAGAR, Nellithanath Thankachen BYJU, Gaurav SAHAL, Arpana Prashant MATHUR, Sanjay Pandurang GAWADE, Dinesh Kanji BHADRA, Devki MOJE
  • Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt
    Patent number: 7615571
    Abstract: New compounds useful as synthetic intermediates to synthesize perindopril, a new process for synthesizing perindopril, and new salts of perindopril.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: November 10, 2009
    Assignee: IPCA Laboratories Ltd.
    Inventors: Sanjay Tukaram Gunjal, Dilip Uttam Jadhav, Ashok Kumar, Mathur Arpana, Nalinakshya Balaram Panda, Satish Rajanikant Soudagar
  • Tramadol recovery process
    Patent number: 7470816
    Abstract: A process for the resolution of isomeric tramadol mixtures comprising: providing a purification stock comprising both cis and trans tramadol; contacting the purification stock with an acid under conditions effective to form an acid salt of the cis and trans tramadol in the purification stock; and separating the cis tramadol acid salt from the trans tramadol to obtain a purified cis tramadol acid salt; and optionally converting the cis tramadol acid salt to cis tramadol or to a pharmaceutically active salt thereof.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: December 30, 2008
    Assignee: IPAC Laboratories Limited
    Inventors: Ashok Kumar, Suneel Yeshwant Dike, Satish Rajanikant Soudagar, Chirag Hasmukh Shah, Sandeep Madhavrao Burudkar, Prashant Gautam, Byju Nellithanath Thankachen, Ashvini Saxena, Manavalan Saravanan, Gunjan Pramod Pathak, Virendra Pal, Rahul Karde, Jaysingh Gehlot
  • Process for preparation of perindopril erbumine in alpha crystalline form
    Publication number: 20080183011
    Abstract: Processes for the production of high purity perindopril erbumine in alpha crystalline form, which is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors is disclosed. The process involves isolating the alpha crystalline form in a solvent selected from the group consisting of a C5-C10 hydrocarbon solvent, a mixture of hydrocarbon with esters, a primary alcohol, a secondary alcohol, a tertiary alcohol, a mixture of ester with alcohol, a nitrile, an ether, a ketoester, a dipolar solvent, and isopropyl acetate.
    Type: Application
    Filed: November 6, 2007
    Publication date: July 31, 2008
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Arpana Mathur, Nalinakshya Balaram Panda
  • Process For Synthesis Of Gabapentin
    Publication number: 20080103334
    Abstract: A process for preparation of gabapentin comprising a step of obtaining 1,1-cyclohexane diacetic acid monoamide from 1,1-cyclohexane diacetic acid anhydride, wherein said reaction is characterized by the use of ammonia precursor or pre-generated ammonia-isopropanol solution. The invention further discloses preparation of gabapentin and isolation of gabapentin in polymorphic Form II with high yield and purity.
    Type: Application
    Filed: October 24, 2007
    Publication date: May 1, 2008
    Applicant: IPCA Laboratories Ltd
    Inventors: Ashok Kumar, Satish Rajanikant Soudagar, Avinash Manohar Nijasure, Nalinakshya Balaram Panda, Prashant Gautam, Gajendrasingh Ramsingh Thakur
  • Process for the synthesis of Losartan potassium
    Patent number: 7345071
    Abstract: Improved processes using primary, secondary and tertiary alcohols and with safer mode of introduction of the reagent and reaction conditions are described. Further, the process of manufacture of Losartan potassium by use of alkali metal salt such as Potassium carbonate is disclosed. A process for preparation of the polymorphic Form I of Losartan potassium is also disclosed herein.
    Type: Grant
    Filed: August 5, 2004
    Date of Patent: March 18, 2008
    Assignee: IPCA Laboratories Limited
    Inventors: Ashok Kumar, Rajesh Kumar Keshava Prasad Singh, Nalinakshya Balaram Panda, Abhay Atmaram Upare, Manmohan Madhavrao Nimbalkar, Satish Rajanikant Soudagar, Ashvini Kumar Nand Kishore Saxena